• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

托拉塞米在人体中的药代动力学研究:其利尿作用概述

Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect.

作者信息

Lesne M, Clerckx-Braun F, Duhoux P, van Ypersele de Strihou C

出版信息

Int J Clin Pharmacol Ther Toxicol. 1982 Aug;20(8):382-7.

PMID:7118326
Abstract

A new diuretic drug, torasemide, after oral or i. v. administration of 20 mg to six normal volunteers showed good bioavailability (greater than 91%). Its biologic half-life is about 2.5 h with a distribution volume of 180 ml/kg and a body clearance of 0.8 ml/min kg. The renal excretion represents only 25% of the total drug elimination. The excretion of water, sodium, potassium, and chloride parallels the renal excretion of torasemide. The diuretic action has a duration of 6 h, reaching its maxima during the 1st h after i. v. administration an during the 2nd h after oral administration.

摘要

一种新型利尿药托拉塞米,给6名正常志愿者口服或静脉注射20毫克后,显示出良好的生物利用度(大于91%)。其生物半衰期约为2.5小时,分布容积为180毫升/千克,机体清除率为0.8毫升/分钟·千克。肾脏排泄仅占药物总消除量的25%。水、钠、钾和氯的排泄与托拉塞米的肾脏排泄平行。利尿作用持续6小时,静脉注射后第1小时和口服后第2小时达到最大值。

相似文献

1
Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect.托拉塞米在人体中的药代动力学研究:其利尿作用概述
Int J Clin Pharmacol Ther Toxicol. 1982 Aug;20(8):382-7.
2
Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.托拉塞米与呋塞米在健康志愿者体内的药代动力学和药效学比较。
Arzneimittelforschung. 1988 Jan;38(1A):160-3.
3
Study of the tolerance and diuretic properties of torasemide following oral or intravenous administration to healthy volunteers.对健康志愿者口服或静脉注射托拉塞米后的耐受性和利尿特性的研究。
Eur J Clin Pharmacol. 1986;31 Suppl:9-14. doi: 10.1007/BF00541461.
4
Pharmacokinetics and metabolism of torasemide in man.托拉塞米在人体中的药代动力学与代谢
Arzneimittelforschung. 1988 Jan;38(1A):164-6.
5
A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.两种袢利尿剂托拉塞米和呋塞米在正常志愿者体内的药代动力学及利尿效果比较。
Eur J Clin Pharmacol. 1986;31 Suppl:21-7. doi: 10.1007/BF00541463.
6
High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure.高剂量托拉塞米,每日静脉注射一次,持续一周,用于晚期慢性肾衰竭患者。
Clin Nephrol. 1997 Jul;48(1):22-8.
7
An examination of the site and mechanism of action of torasemide in man.
J Clin Pharmacol. 1988 May;28(5):441-7. doi: 10.1002/j.1552-4604.1988.tb05757.x.
8
Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects.托拉塞米在正常受试者慢性治疗期间的利尿活性、安全性及药代动力学
Eur J Clin Pharmacol. 1986;31 Suppl:1-7. doi: 10.1007/BF00541460.
9
Pharmacological properties of the new potent diuretic torasemide in rats and dogs.新型强效利尿剂托拉塞米在大鼠和犬体内的药理特性
Arzneimittelforschung. 1985;35(10):1520-6.
10
Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency.新型袢利尿剂托拉塞米在肾功能不全患者体内的消除动力学研究。
Eur J Clin Pharmacol. 1986;31 Suppl:49-51. doi: 10.1007/BF00541467.

引用本文的文献

1
Diuretic Resistance.利尿剂抵抗
Am J Kidney Dis. 2017 Jan;69(1):136-142. doi: 10.1053/j.ajkd.2016.08.027. Epub 2016 Nov 1.
2
A simplified HPLC method for quantification of torsemide from human plasma and its application to a bioequivalence study.一种用于定量测定人血浆中托拉塞米的简化高效液相色谱法及其在生物等效性研究中的应用。
Indian J Pharm Sci. 2008 Jul-Aug;70(4):519-22. doi: 10.4103/0250-474X.44609.
3
Pharmacokinetics and pharmacodynamics of torasemide in patients with chronic renal insufficiency--preliminary evaluation.
托拉塞米在慢性肾功能不全患者中的药代动力学和药效学——初步评估
Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:69-73. doi: 10.1007/BF00877960.
4
Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.健康受试者单次及重复使用利尿剂后的肾脏排泄反应:临床意义
Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:29-44. doi: 10.1007/BF00877956.
5
Torasemide. An update of its pharmacological properties and therapeutic efficacy.托拉塞米。其药理特性与治疗效果的最新进展。
Drugs. 1995 Jan;49(1):121-42. doi: 10.2165/00003495-199549010-00009.
6
Study of the tolerance and diuretic properties of torasemide following oral or intravenous administration to healthy volunteers.对健康志愿者口服或静脉注射托拉塞米后的耐受性和利尿特性的研究。
Eur J Clin Pharmacol. 1986;31 Suppl:9-14. doi: 10.1007/BF00541461.
7
The influence of haemodialysis and haemofiltration on the clearance of torasemide in renal failure.血液透析和血液滤过对肾衰竭患者托拉塞米清除率的影响。
Eur J Clin Pharmacol. 1986;31 Suppl:53-5. doi: 10.1007/BF00541468.
8
Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency.新型袢利尿剂托拉塞米在肾功能不全患者体内的消除动力学研究。
Eur J Clin Pharmacol. 1986;31 Suppl:49-51. doi: 10.1007/BF00541467.
9
Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.托拉塞米和呋塞米在慢性心力衰竭中的利尿活性:一项比较性双盲交叉研究。
Eur J Clin Pharmacol. 1986;31 Suppl:35-42. doi: 10.1007/BF00541465.
10
A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.两种袢利尿剂托拉塞米和呋塞米在正常志愿者体内的药代动力学及利尿效果比较。
Eur J Clin Pharmacol. 1986;31 Suppl:21-7. doi: 10.1007/BF00541463.